Once-daily USL255 as adjunctive treatment of partial-onset seizures: Randomized phase III study

OBJECTIVE: To evaluate the efficacy and safety of USL255, Qudexy™ XR (topiramate) extended-release capsules, as an adjunctive treatment for refractory partial-onset seizures (POS) in adults taking one to three concomitant antiepileptic drugs. METHODS: In this global phase III study (PREVAIL; NCT0114...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Steve S, Fakhoury, Toufic A, Hogan, R Edward, Nagaraddi, Venkatesh N, Blatt, Ilan, Lawson, Balduin, Arnold, Stephan, Anders, Bob, Clark, Annie M, Laine, Dawn, Meadows, R Shawn, Halvorsen, Mark B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Full-Length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143954/
https://www.ncbi.nlm.nih.gov/pubmed/24902983
http://dx.doi.org/10.1111/epi.12660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143954/
https://www.ncbi.nlm.nih.gov/pubmed/24902983
http://dx.doi.org/10.1111/epi.12660

Ejemplares similares